West Pharmaceutical Services Profit Margins 2006-2018 | WST

Current and historical gross, operating and net profit margins for West Pharmaceutical Services (WST) over the last 10 years. The current net profit margin for West Pharmaceutical Services as of June 30, 2018 is 8.99%.
West Pharmaceutical Services Annual Profit Margin Summary
West Pharmaceutical Services Quarterly Profit Margin Summary
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $8.466B $1.599B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $66.417B 23.78
Align Technology (ALGN) United States $29.098B 77.58
McKesson (MCK) United States $25.177B 9.64
Laboratory Of America Holdings (LH) United States $18.319B 16.85
AmerisourceBergen (ABC) United States $17.971B 13.06
Cardinal Health (CAH) United States $15.242B 10.22
Cooper (COO) United States $12.433B 23.14
Henry Schein (HSIC) United States $11.915B 20.32
DENTSPLY SIRONA (XRAY) United States $8.798B 15.40
Merit Medical Systems (MMSI) United States $3.008B 39.53
Patterson (PDCO) United States $2.177B 13.63
CONMED (CNMD) United States $2.159B 36.58
STAAR Surgical (STAA) United States $1.742B 233.24
Atrion (ATRI) United States $1.193B 35.37
Invacare (IVC) United States $0.550B 0.00
Antares Pharma (ATRS) United States $0.504B 0.00
Endologix (ELGX) United States $0.232B 0.00
Lifevantage (LFVN) United States $0.139B 28.82
Aceto (ACET) United States $0.098B 3.97
Biolase (BIOL) United States $0.030B 0.00
Pro-Dex (PDEX) United States $0.029B 12.61
Milestone Scientific (MLSS) United States $0.028B 0.00
Retractable Technologies (RVP) United States $0.025B 0.00